SERA
HEALTHCARESera Prognostics Inc Class A
Live · NASDAQ · May 9, Close
What's Moving SERA Today?
No stock-specific AI insight has been generated for SERA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.81
Fundamentals
Trading
SERA News
20 articles- Will Sera Prognostics (NASDAQ:SERA) Spend Its Cash Wisely?Yahoo Finance·May 8, 2026
- Sera Prognostics, Inc. Q1 2026 Earnings Call SummaryMoby·May 7, 2026
- Sera Prognostics Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 6, 2026
- SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSYahoo Finance·May 6, 2026
- SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026Yahoo Finance·Apr 22, 2026
- Sera Prognostics (SERA) Upgraded to Buy: What Does It Mean for the Stock?Yahoo Finance·Mar 31, 2026
- 5 Top-Ranked Stocks With Rising P/E That Investors Can Bet OnYahoo Finance·Mar 31, 2026
- Sera Prognostics, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 19, 2026
- Sera Prognostics Inc (SERA) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges and ...Yahoo Finance·Mar 19, 2026
- Sera Prognostics Q4 Earnings Call HighlightsMarketbeat·Mar 18, 2026
- Sera Prognostics Q4 2025 Earnings Call TranscriptMotley Fool·Mar 18, 2026
- Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Mar 18, 2026
- SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTSYahoo Finance·Mar 18, 2026
- Sera Prognostics Inc (SERA) Q4 2025: Everything You Need To Know Ahead Of EarningsYahoo Finance·Mar 17, 2026
- The Joint Corp. (JYNT) Beats Q4 Earnings and Revenue EstimatesYahoo Finance·Mar 12, 2026
- LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Mar 9, 2026
- SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026Yahoo Finance·Mar 4, 2026
- SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCEYahoo Finance·Feb 17, 2026
- Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn ComplicationsYahoo Finance·Jan 7, 2026
All 20 articles loaded
Price Data
52-Week Range
$1.81
Fundamentals
Trading
About Sera Prognostics Inc Class A
Sera Prognostics Inc. is a leader in maternal-fetal health, specializing in innovative diagnostic solutions aimed at improving pregnancy outcomes. The company's flagship product, the PreTRM test, utilizes a proprietary biomarker platform to accurately assess the risk of preterm birth, facilitating timely interventions by healthcare providers. With a commitment to advancing prenatal diagnostics and enhancing maternal health, Sera is well-positioned for growth in this critical market segment. The company’s innovative approach not only addresses urgent clinical needs but also supports long-term value creation for its investors.